Headquartered in Cambridge, Massachusetts, Biogen Inc. (BIIB) researches, develops, and commercializes therapies for severe ...

Key recent performance and business profile Biogen (BIIB) has moved quietly higher, with the share price showing a 0.8% decline over the last day but gains of 1.5% over the past week and 18.1% over ...

Biogen reported revenue of $2.28 billion and adjusted earnings per share of $1.99 for the quarter, exceeding both Canaccord’s estimates of $2.17 billion and $1.70 and consensus expectations of $2.20 ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...

Biogen Inc. (NASDAQ:BIIB) is one of the best medical research stocks to buy according to hedge funds. On February 10, Wedbush lifted the price target on Biogen Inc. (NASDAQ:BIIB) to $187 from $178, ...

Biogen Inc. (BIIB) stock reached a 52-week high, peaking at 190.34 USD, underscoring a robust performance over the past year. The stock has experienced a notable 31.14% increase over the last 12 ...

Investors in Biogen Inc (Symbol: BIIB) saw new options become available today, for the June 2027 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Investors in Biogen Inc (Symbol: BIIB) saw new options become available today, for the December 19th expiration. One of the key data points that goes into the price an option buyer is willing to pay, ...

On February 11, 2026, Biogen announced that Caroline Dorsa, Chair of the company’s Board of Directors, will not stand for re-election at the 2026 Annual Meeting of Stockholders. The company stated ...

Biogen is transitioning from a shrinking MS franchise to a portfolio anchored in rare disease and Alzheimer’s therapies, ...